Why Inhibrx's Stock Is Trading Higher Today

Inhibrx INBX shares are trading higher on Monday after multiple firms initiated coverage on the stock with a bullish rating.

Inhibrx is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates.

Inhibrx shares were trading up 6.49% at $8.21 on Monday during the time of publication. The stock has a 52-week high of $26.98 and a 52-week low of $15.76.

Loading...
Loading...
INBX Logo
INBXInhibrx Biosciences Inc
$14.932.51%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
Not Available
Growth
Not Available
Quality
Not Available
Value
1.05
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Comments
Loading...